Innovent Biologics 2022 Interim Results H1 Earnings

Innovent Biologics' 2022 interim results presentation covering first-half business performance and financial position. The presentation includes forward-looking statements regarding the company's clinical development pipeline, business strategy, and operational objectives in the competitive biotech sector.